Brief: Unichem Laboratories Receives ANDA Approval For Its Doxazosin Tablets From US FDA
Jan 11 (Reuters) - Unichem Laboratories Ltd UNLB.NS :
* RECEIVED ANDA APPROVAL FOR ITS DOXAZOSIN TABLETS USP, 1
MG, 2
MG, 4 MG AND 8 MG
* RECEIVED ANDA APPROVAL FOR ITS DOXAZOSIN TABLETS FROM
USFDA
* PRODUCT WILL BE COMMERCIALIZED FROM UNICHEM'S GOA PLANT
Source text for Eikon: ID:nBSE45sG7p
Further company coverage: UNLB.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unichem Laboratories
See all newsIndia's Unichem Laboratories drops after US FDA inspection ends with five observations
India's Unichem Labs falls after appeal against tax demand rejected
Brief: Unichem Laboratories June-Quarter Consol PAT 414.7 Million Rupees
India's Unichem Laboratories jumps on posting Q1 profit
India's Unichem Laboratories surges in busiest session ever after block deal at premium